Search results
Austin to host MLS All-Star game in 2025 as Texas capital continues to grow as a soccer market
KSLA-TV Shreveport· 1 hour agoAustin FC’s Q2 Stadium will host the 2025 Major League Soccer All-Star match, Commissioner Don...
Buy the Dip: 3 Growth Stocks Poised for a Rapid Rebound
InvestorPlace· 1 hour agoFinding stable investment options is essential for investors looking to grow despite market volatility in today’s unpredictable environment. The first business is growing steadily in the direct-to-consumer ...
Deere (DE) Q2 Earnings & Sales Top Estimates, '24 View Dips
Zacks via Yahoo Finance· 5 hours agoDeere & Company DE shares fell 5.1% in the pre-market trading, as the company cut down its 2024...
Globant shares slip 6% on disappointing Q2 guidance By Investing.com
Investing.com· 1 hour agoGlobant (NYSE: GLOB), the digitally native company specializing in reinventing businesses through...
Q2 2024 EPS Estimates for AlloVir, Inc. Decreased by Leerink Partnrs (NASDAQ:ALVR)
ETF DAILY NEWS· 14 hours agoAlloVir, Inc. (NASDAQ:ALVR – Free Report) – Investment analysts at Leerink Partnrs cut their Q2 2024 EPS estimates for AlloVir in a research report issued on Monday, May 13th ...
Deere Q2 Results Top Street but It Cuts 2024 Profit Outlook Again as Farmers Buy Fewer Tractors
US News & World Report· 9 hours agoDeere's fiscal second-quarter results beat Wall Street's expectations, but the company lowered its full-year profit forecast for a second time as farmers buy fewer tractors and other equipment ...
Applied Materials Q2 Earnings: Revenue Beat, EPS Beat, Positioned For Growth In AI, EVs, Clean...
Benzinga· 1 hour agoApplied Materials said second-quarter revenue was flat on a year-over-year basis. The chip equipment...
Applied Materials beats Q2 estimates but guidance disappoints | Invezz
Invezz· 1 hour agoApplied Materials reported its financial results for the second quarter today. Here's what its CEO...
Deere reports a strong Q2 but trims guidance | Invezz
Invezz· 11 hours agoDeere reported its financial results for the second quarter on Thursday. Here's what its CEO John C....
Jasper Therapeutics, Inc. Expected to Post Q2 2024 Earnings of ($0.96) Per Share (NASDAQ:JSPR)
ETF DAILY NEWS· 15 hours agoJasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Research analysts at William Blair raised their Q2 2024 earnings estimates for Jasper Therapeutics in a research note ...
